Study indicates that the modified drug still is an effective pain reliever but likely doesn’t have as many potentially deadly side effects.

The wastewater draining from massive pools of sewage sludge has the potential to play a role in more sustainable agriculture.

Their new demonstrations show that it converts heat to electricity with over 40 percent efficiency a performance better than steam turbines.

A single-atom-thin material that has been coined “white graphene” for its transparent appearance and its similarity to carbon-based graphene

One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier.

The exoskeleton personalizes assistance as people walk normally through the real world resulting in exceptional improvements in walking.

Researchers have developed a new kind of battery, made entirely from abundant and inexpensive materials, that could help to fill that gap.

In the new JEM study, teams used a computer-based screening approach to identify a drug, named C26, that activates NR2F1.

Watson College of Engineering has been working for years on biobatteries, which generate electricity through bacterial interaction.

Methane gas is 86 times more potent than CO2 and accounts for 30 percent of all global warming from gaseous emissions.

Scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine.

Researchers successfully detect lung cancer in more than 80% of liver cancers in a new study of 724 people at Johns Hopkins Cancer Center.

Over-the-counter pain relievers, physical therapy, steroid injections -- some people have tried it all and are still dealing with knee pain.

Developing a sensor system for quickly testing their saliva to see if they have the correct level of anti-epileptic medicine in their system

An ambitious company is offering what it is calling “the world’s first and only handheld Gauss rifle” for pre-order for the price of $3,375.

"There are many kinds of this medicine in trials, but this is the first to be approved," she said. "It is pretty remarkable."

Researchers have developed a synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immune activation.

A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists.

To observe living cells through a microscope, a sample is usually squeezed onto a glass slide and the cells are observed in two dimensions.

When COVID-19 occurred, we wanted to study the therapy’s potential and discovered it was effective against every type of coronavirus.